MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-11-2026
Stryker Corporation Total Liabilities 2011-2026 | SYK
Annual Total Liabilities Stryker Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25.4 B | 22.3 B | 21.3 B | 20.3 B | 19.8 B | 21.2 B | 17.4 B | 15.5 B | 12.2 B | 10.9 B | 7.74 B | 9.12 B | 6.7 B | 4.61 B | 4.72 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 25.4 B | 4.61 B | 14.6 B |
Quarterly Total Liabilities Stryker Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25.3 B | 25.1 B | 25.1 B | 23.7 B | 19.4 B | 20.2 B | 20.1 B | 20 B | 19.9 B | 20.3 B | 19.5 B | - | 21.1 B | 19.8 B | 20 B | 19.9 B | 20 B | 21.2 B | 21.2 B | 21.2 B | 21.2 B | 17.4 B | 17.4 B | 17.4 B | 17.4 B | 15.5 B | 15.5 B | 15.5 B | 15.5 B | 12.2 B | 12.2 B | 12.2 B | 12.2 B | 10.9 B | 10.9 B | 10.9 B | 10.9 B | 7.71 B | 7.71 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 25.3 B | 7.71 B | 17.5 B |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B |  USA |
 |
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
2.79 B | $ 12.07 | 0.33 % | $ 1.63 B | USA |
 |
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | USA |
 |
EDAP TMS S.A.
EDAP
|
34.6 M | $ 3.45 | 1.77 % | $ 129 M |  France |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | USA |
 |
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | USA |
 |
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | USA |
 |
Align Technology
ALGN
|
2.36 B | $ 171.87 | 0.74 % | $ 12.9 B | USA |
 |
AxoGen
AXGN
|
92.8 M | $ 32.64 | -5.23 % | $ 1.5 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14 M | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
87.2 M | $ 4.13 | 0.49 % | $ 874 M | USA |
 |
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | USA |
 |
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | USA |
 |
Bruker Corporation
BRKR
|
3.99 B | $ 36.74 | -0.05 % | $ 5.47 K | USA |
 |
BioSig Technologies
BSGM
|
54.2 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
16.7 B | $ 62.59 | -0.37 % | $ 92.7 B | USA |
 |
Alphatec Holdings
ATEC
|
126 M | $ 10.97 | 1.29 % | $ 1.65 B | USA |
 |
CONMED Corporation
CNMD
|
1.29 B | - | - | $ 1.06 B | USA |
 |
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
69.7 M | $ 9.38 | 0.11 % | $ 266 M | USA |
 |
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
38.3 M | $ 0.59 | 1.2 % | $ 36.7 M | USA |
 |
Cutera
CUTR
|
518 M | - | -10.19 % | $ 1.99 M | USA |
 |
Delcath Systems
DCTH
|
12.4 M | $ 9.7 | 0.73 % | $ 347 M | USA |
 |
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
3.36 B | $ 81.19 | 0.17 % | $ 47.5 B | USA |
 |
Second Sight Medical Products
EYES
|
23.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
10.6 M | $ 23.61 | 1.37 % | $ 200 M | USA |
 |
FONAR Corporation
FONR
|
53.1 M | $ 18.6 | 0.05 % | $ 122 M | USA |
 |
Globus Medical
GMED
|
730 M | $ 88.6 | 0.77 % | $ 12 B | USA |
 |
Helius Medical Technologies
HSDT
|
5.34 M | $ 1.9 | 2.15 % | $ 1.15 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
2.49 B | $ 9.31 | -2.31 % | $ 717 M | USA |
 |
Inogen
INGN
|
106 M | $ 6.36 | 2.42 % | $ 169 M | USA |
 |
Inspire Medical Systems
INSP
|
126 M | $ 54.14 | -1.55 % | $ 1.59 B | USA |
 |
IRIDEX Corporation
IRIX
|
24.2 M | $ 1.0 | 1.66 % | $ 16.9 M | USA |
 |
IRadimed Corporation
IRMD
|
14.2 M | $ 95.66 | -0.59 % | $ 1.22 B | USA |
 |
Integer Holdings Corporation
ITGR
|
1.66 B | $ 85.63 | -1.4 % | $ 2.97 B | USA |
 |
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | USA |
 |
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | USA |